Immunosuppression minimization in kidney transplantation.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Frontiers in Bioscience

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2741/2771PMID 17981639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study

  2008cited by this paper
• Protocol Biopsies in Renal Transplantation: Insights into Patient Management and Pathogenesis

  2007cited by this paper
• Mycophenolate Mofetil/Sirolimus Compared to Other Common Immunosuppressive Regimens in Kidney Transplantation

  2007cited by this paper
• Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study

  2007cited by this paper
• Cancer Incidence Before and After Kidney Transplantation

  2007cited by this paper
• Infiltrates in Protocol Biopsies from Renal Allografts

  2007cited by this paper
• Kidney Transplantation With Sirolimus and Mycophenolate Mofetil–Based Immunosuppression: 5-Year Results of a Randomized Prospective Trial Compared to Calcineurin Inhibitor Drugs

  2007cited by this paper
• Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

  2007cited by this paper
• Long‐Term Renal Allograft Function on a Tacrolimus‐Based, Pred‐Free Maintenance Immunosuppression Comparing Sirolimus vs. MMF †

  2006cited by this paper
• Three-Year Observational Follow-up of a Multicenter, Randomized Trial on Tacrolimus-Based Therapy with Withdrawal of Steroids or Mycophenolate Mofetil after Renal Transplant

  2006cited by this paper
• Randomized Controlled Trial of FTY720 Versus MMF in De Novo Renal Transplantation

  2006cited by this paper
• Alemtuzumab (Campath-1H): A Systematic Review in Organ Transplantation

  2006cited by this paper
• Cancer incidence before and after kidney transplantation.

  2006cited by this paper
• Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil.

  2006cited by this paper
• Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies.

  2006cited by this paper
• Conversion From Calcineurin Inhibitors to Sirolimus for Chronic Renal Allograft Dysfunction: A Systematic Review of the Evidence

  2006cited by this paper
• Late Low‐Dose Steroid Withdrawal in Renal Transplant Recipients Increases Bone Formation and Bone Mineral Density

  2006cited by this paper
• Complete Avoidance of Calcineurin Inhibitors in Renal Transplantation: A Randomized Trial Comparing Sirolimus and Tacrolimus

  2006cited by this paper
• Calcineurin Inhibitor Avoidance with Daclizumab, Mycophenolate Mofetil, and Prednisolone in DR-Matched de Novo Kidney Transplant Recipients

  2006cited by this paper
• Costimulation Blockade With Belatacept in Renal Transplantation

  2006influential reference
• Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation

  2006cited by this paper
• Alemtuzumab Induction and Prednisone‐Free Maintenance Immunotherapy in Simultaneous Pancreas‐Kidney Transplantation Comparison With Rabbit Antithymocyte Globulin Induction – Long‐Term Results

  2006cited by this paper
• Steroid-free immunosuppression after renal transplantation-long-term experience from a single centre.

  2006cited by this paper
• Slowing the Progression of Chronic Allograft Nephropathy by Conversion from Cyclosporine to Tacrolimus: A Randomized Controlled Trial

  2006cited by this paper
• Concentrations of cyclosporin A and FK506 that inhibit IL‐2 induction in human T cells do not affect TGF‐β1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF‐β1

  2005cited by this paper
• Two Corticosteroid-Free Regimens—Tacrolimus Monotherapy after Basiliximab Administration and Tacrolimus/Mycophenolate Mofetil—in Comparison with a Standard Triple Regimen in Renal Transplantation: Results of the Atlas Study

  2005cited by this paper
• A Prospective Randomized Trial of Steroid‐Free Maintenance Regimens in Kidney Transplant Recipients—An Interim Analysis

  2005cited by this paper
• Minimization of Immunosuppressive Therapy After Renal Transplantation: Results of a Randomized Controlled Trial

  2005cited by this paper
• Calcineurin Inhibitor- and Steroid-Free Immunosuppression in Pancreas-Kidney and Solitary Pancreas Transplantation

  2005cited by this paper
• Corticosteroid-Free Immunosuppression with Tacrolimus, Mycophenolate Mofetil, and Daclizumab Induction in Renal Transplantation

  2005cited by this paper
• Switching from Cyclosporine to Tacrolimus in Patients with Chronic Transplant Dysfunction or Cyclosporine-Induced Adverse Events

  2005cited by this paper
• Alemtuzumab Induction and Prednisone‐Free Maintenance Immunotherapy in Kidney Transplantation: Comparison with Basiliximab Induction—Long‐Term Results

  2005cited by this paper
• A Multicenter Pilot Study of Early (4‐Day) Steroid Cessation in Renal Transplant Recipients Under Simulect, Tacrolimus and Sirolimus

  2005cited by this paper
• Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation—Efficacy and Safety at Five Years

  2005cited by this paper
• Comparison of Sirolimus with Low‐Dose Tacrolimus Versus Sirolimus‐based Calcineurin Inhibitor‐Free Regimen in Live Donor Renal Transplantation

  2005cited by this paper
• The effect of different immunosuppressive regimens on TGF‐β1 expression in kidney transplant patients

  2005cited by this paper
• 2005 Immunosuppressive Strategies in Kidney Transplantation: Which Role for the Calcineurin Inhibitors?

  2005cited by this paper
• Transplantation for the treatment of intra-abdominal fibromatosis.

  2005cited by this paper
• Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus.

  2005cited by this paper
• Prednisone‐Free Maintenance Immunosuppression—A 5‐Year Experience

  2005cited by this paper
• Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.

  2005influential reference
• Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus‐based regimens

  2005cited by this paper
• Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.

  2005cited by this paper
• Randomized Trial of Alemtuzumab for Prevention of Graft Rejection and Preservation of Renal Function after Kidney Transplantation1

  2005cited by this paper
• Long‐Term Prospective Study of Steroid Withdrawal in Kidney and Heart Transplant Recipients

  2005cited by this paper
• Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.

  2005cited by this paper
• Steroid Avoidance Versus Steroid Withdrawal After Simultaneous Pancreas‐Kidney Transplantation

  2005cited by this paper
• A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.

  2005cited by this paper
• Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.

  2005cited by this paper
• A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• Baseline Immunosuppression is Associated with Histological Findings in Early Protocol Biopsies

  2004cited by this paper
• Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors

  2004cited by this paper
• Withdrawal of Cyclosporine or Tacrolimus After Addition of Mycophenolate Mofetil in Patients With Chronic Allograft Nephropathy

  2004influential reference
• Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial

  2004cited by this paper
• Improving long-term renal transplant outcomes with tacrolimus: speculation vs evidence.

  2004cited by this paper
• Chronic allograft nephropathy.

  2004cited by this paper
• Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.

  2004cited by this paper
• What's New—What's Hot in Clinical Science: American Transplant Congress 2004

  2004cited by this paper
• De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at Two Years

  2004cited by this paper
• The Use of Campath-1H as Induction Therapy in Renal Transplantation: Preliminary Results

  2004cited by this paper
• Steroid‐Withdrawal at 3 Days After Renal Transplantation with Anti‐IL‐2 Receptor α Therapy: A Prospective, Randomized, Multicenter Study

  2004cited by this paper
• Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era

  2004influential reference
• Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction *

  2004cited by this paper
• CARDIOVASCULAR RISK PROFILE AFTER CONVERSION FROM CYCLOSPORINE A TO TACROLIMUS IN STABLE RENAL TRANSPLANT RECIPIENTS

  2004cited by this paper
• Conversion from Cyclosporine to Tacrolimus Improves Quality‐of‐Life Indices, Renal Graft Function and Cardiovascular Risk Profile

  2004cited by this paper
• Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.

  2004cited by this paper
• A PILOT STUDY OF RAPID STEROID ELIMINATION WITH ALEMTUZUMAB INDUCTION THERAPY IN KIDNEY AND PANCREAS TRANSPLANTATION

  2004cited by this paper
• Conversion from Cyclosporine to Tacrolimus Improves Quality‐of‐Life Indices, Renal Graft Function and Cardiovascular Risk Profile

  2004cited by this paper
• Tailored immunosuppression and steroid withdrawal in pancreas-kidney transplantation.

  2004cited by this paper
• Tolerogenic immunosuppression for organ transplantation.

  2003cited by this paper
• Multicenter Randomized Prospective Trial of Steroid Withdrawal in Renal Transplant Recipients Receiving Basiliximab, Cyclosporine Microemulsion and Mycophenolate Mofetil

  2003cited by this paper
• A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation

  2003cited by this paper
• Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.

  2003cited by this paper
• Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.

  2003cited by this paper
• Campath‐1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study

  2003influential reference
• Chronic renal failure after transplantation of a nonrenal organ.

  2003cited by this paper
• RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52‐SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH‐1H)

  2003cited by this paper
• Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.

  2003cited by this paper
• Chronic renal failure after transplantation of a nonrenal organ.

  2003cited by this paper
• Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years

  2003cited by this paper
• Immunosuppression minimization: current and future trends in transplant immunosuppression.

  2003cited by this paper
• Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation1

  2003cited by this paper
• The problem of late allograft loss in kidney transplantation.

  2003cited by this paper
• Long-term graft survival with neoral and tacrolimus: a paired kidney analysis.

  2003cited by this paper
• The natural history of chronic allograft nephropathy.

  2003cited by this paper
• The role of B cells and alloantibody in the host response to human organ allografts

  2003cited by this paper
• Diagnosis and treatment of antibody-mediated kidney allograft rejection

  2003cited by this paper
• Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study.

  2002cited by this paper
• Five preventable causes of kidney graft loss in the 1990s: a single-center analysis.

  2002cited by this paper
• Strategies to improve long-term outcomes after renal transplantation.

  2002influential reference
• Call for Revolution: A New Approach to Describing Allograft Deterioration

  2002cited by this paper
• Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination1, 2

  2002influential reference
• Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil.

  2002cited by this paper
• Cyclosporine withdrawal from a mycophenolate mofetil–containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study1,2

  2002cited by this paper
• Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study.

  2002cited by this paper
• What's in the Pipeline? New Immunosuppressive Drugs in Transplantation

  2002influential reference
• A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.

  2002cited by this paper
• A PROSPECTIVE STUDY OF RAPID CORTICOSTEROID ELIMINATION IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: Comparison of Two Maintenance Immunosuppression Protocols: Tacrolimus/Mycophenolate Mofetil Versus Tacrolimus/Sirolimus1

  2002cited by this paper
• Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine1

  2002cited by this paper

• Retraction Retracted: The Prevalence of Neurological Complication after Renal Transplantation

  2023cites this paper
• The Prevalence of Neurological Complication after Renal Transplantation

  2022cites this paper
• CD45RC Expression of Circulating CD8+ T Cells Predicts Acute Allograft Rejection: A Cohort Study of 128 Kidney Transplant Patients

  2019cites this paper
• Lung Transplantation and Precision Medicine

  2019cites this paper
• Optimizing everolimus exposure when combined with calcineurin inhibitors in solid organ transplantation.

  2017cites this paper
• Pharmacology of transplantation

  2011cites this paper
• Schemi di terapia immunosoppressiva e livelli ematici consigliati

  2011cites this paper
• The synergistic effects of C. Sinensis with CsA in preventing allograft rejection.

  2009influential citation
• Two‐year follow‐up of a prospective study of circulating regulatory T cells in renal transplant patients

  2009cites this paper
• Can immune monitoring help to minimize immunosuppression in kidney transplantation?

  2009cites this paper
• TLR Activation Prevents Hematopoietic Chimerism Induced by Costimulation Blockade: A Dissertation

  2008cites this paper
• Role of innate immunity in transplantation tolerance.

  2008cites this paper
• Maintenance immunosuppressive therapy in adult renal transplantation: a single center analysis.

  2008cites this paper
• Viral Infection: A Potent Barrier to Transplantation Tolerance

  2008cites this paper